About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker KROS

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Oct 27, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
BlackRock Portfolio Management LLC1.81M9.1%SCHEDULE 13G/A ↗
Jul 29, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
BlackRock, Inc.1.67M8.4%SCHEDULE 13G/A ↗
Jul 17, 2026SCHEDULE 13GKROS
Keros Therapeutics, Inc.
BlackRock Portfolio Management LLC1.12M5.7%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Daniel Mack1.36M6.9%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Wilmot B. Harkey1.36M6.9%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Nantahala Capital Management, LLC1.36M6.9%SCHEDULE 13G ↗
Apr 7, 2026SCHEDULE 13GKROS
Keros Therapeutics, Inc.
BlackRock, Inc.1.99M10.1%SCHEDULE 13G ↗
Mar 27, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
The Vanguard Group00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Tang Capital Partners IV, Inc00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Tang Capital Partners III, Inc00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Tang Capital Partners International, LP00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Tang Capital Partners, LP00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Kevin Tang00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Tang Capital Management, LLC00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
David E. Shaw756,1563.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
D. E. Shaw & Co., L.L.C.755,4733.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
D. E. Shaw & Co., L.P.756,1563.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Eli Samaha823,7072.7%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Caraway Jackson Investments LLC823,7072.7%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Madison Avenue GP, LLC823,7072.7%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
EMAI Management, LLC823,7072.7%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Madison Avenue Partners, LP823,7072.7%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Madison Avenue International LP823,7072.7%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
Michael Gelband13,3600.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
ExodusPoint Capital Partners GP, LLC13,3600.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
ExodusPoint Capital Management, LP13,3600.0%SCHEDULE 13G/A ↗
Jan 30, 2026SCHEDULE 13G/A (amended)KROS
Keros Therapeutics, Inc.
The Vanguard Group1.53M5.0%SCHEDULE 13G/A ↗
Nov 18, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Michael Gelband1.91M6.3%SCHEDULE 13G ↗
Nov 18, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
ExodusPoint Capital Partners GP, LLC1.91M6.3%SCHEDULE 13G ↗
Nov 18, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
ExodusPoint Capital Management, LP1.91M6.3%SCHEDULE 13G ↗
Oct 27, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
David E. Shaw1.55M5.1%SCHEDULE 13G ↗
Oct 27, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
D. E. Shaw & Co., L.L.C.1.54M5.0%SCHEDULE 13G ↗
Oct 27, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
D. E. Shaw & Co., L.P.1.55M5.1%SCHEDULE 13G ↗
Oct 22, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Tang Capital Partners IV, Inc00.0%SCHEDULE 13G ↗
Oct 22, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Tang Capital Partners III, Inc00.0%SCHEDULE 13G ↗
Oct 22, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Tang Capital Partners International, LP839,7472.7%SCHEDULE 13G ↗
Oct 22, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Tang Capital Partners, LP1.58M5.2%SCHEDULE 13G ↗
Oct 22, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Kevin Tang2.42M7.9%SCHEDULE 13G ↗
Oct 22, 2025SCHEDULE 13GKROS
Keros Therapeutics, Inc.
Tang Capital Management, LLC2.42M7.9%SCHEDULE 13G ↗
Oct 16, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Pontifax Late Stage GP Ltd.00.0%SCHEDULE 13D/A ↗
Oct 16, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Pontifax Late Stage Fund L.P.00.0%SCHEDULE 13D/A ↗
Oct 16, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Pontifax (China) IV, L.P.00.0%SCHEDULE 13D/A ↗
Oct 16, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Pontifax (Cayman) IV, L.P.00.0%SCHEDULE 13D/A ↗
Oct 16, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Pontifax (Israel) IV, L.P.00.0%SCHEDULE 13D/A ↗
Oct 16, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Pontifax Management 4 GP (2015) Ltd.00.0%SCHEDULE 13D/A ↗
Oct 15, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Daniel Schneeberger00.0%SCHEDULE 13D/A ↗
Oct 15, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
ADAR1 Capital Management GP, LLC00.0%SCHEDULE 13D/A ↗
Oct 15, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
ADAR1 Capital Management, LLC00.0%SCHEDULE 13D/A ↗
Aug 21, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
Daniel Schneeberger5.39M13.3%SCHEDULE 13D/A ↗
Aug 21, 2025SCHEDULE 13D/A (amended)KROS
Keros Therapeutics, Inc.
ADAR1 Capital Management GP, LLC4.65M11.4%SCHEDULE 13D/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 10:07 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances